My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Sanidad Militar
Print version ISSN 1887-8571
Abstract
GRANDA-LOBATO, P; CORREA-PEREZ, A; SILVA-CUEVAS, M and GARCIA-LUQUE, A. Positive assessment of drugs: from April, May and June of 2022. Sanid. Mil. [online]. 2022, vol.78, n.3, pp.182-187. Epub Jan 30, 2023. ISSN 1887-8571. https://dx.doi.org/0.4321/s1887-857120220003000010.
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public from April to June of 2022, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.
Keywords : Asciminib (Scemblix®); Budesonide (Kinpeygo®); Capmatinib (Travecta®); Efgartigimod Alfa (Vyvgart®); Eladocagene Exuparvovec (Upstaza®); Eptacog Beta Activated (Cevenfacta®); Birch Bark Extract (Fisulvez®); Lasmiditan (Rayvow®); Lenacapavir (Sunlenca®); Melphalan Flufenamide (Pepaxti®); Mosunetuzumab (Lunsumio®); Olipudase Alfa (Xenpozyme®); Lonafarnib (Zokinvy®); COVID-19 vaccine (inactivated, adjuvanted, adsorbed) (Valneva®); Valoctocogene Roxaparvovec (Roctavian®).